Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Richard T. Silver MD Myeloproliferative Neoplasms Center
Explore this Website
Home
For Patients
Toggle For Patients menu options
Conditions
Toggle Conditions menu options
Chronic Myeloid Leukemia
Essential Thrombocythemia
Myelofibrosis
Polycythemia Vera
Chronic Eosinophilic Leukemias
MDS/MPN
MPN-Unclassifiable
Mastocytosis
Complications
Toggle Complications menu options
Bleeding
Cardiovascular Disease (heart failure, pulmonary artery hypertension)
Depression and other mood disorders
Diarrhea and other gastrointestinal complications
Pregnancy and MPNs
Pruritus (Itching)
Thrombosis/Blood Clots
Sexual Dysfunction
Treatments
Toggle Treatments menu options
Anagrelide (Agrylin®)
Anti-Coagulants
Aspirin
Bone Marrow Transplant
Bosutinib (Bosulif®)
Clopidogrel (Plavix®)
DNA Hypomethylating Agents (DHAs)
Dasatinib (Sprycel®)
Erythropoiesis-Stimulating Agents (ESAs)
Hydroxyurea
Imatinib (Gleevec®)
Interferons
Lenalidomide (Revlimid®)
Nilotinib (Tasigna®)
Phosphorous-32
Ponatinib (Iclusig®)
Prednisone
Ruxolitnib
Tyrosine Kinase Inhibitors (TKIs)
Frequently Asked Questions
Resources
Your First Visit
Request an Appointment
For Professionals
Toggle For Professionals menu options
Refer a Patient
Featured Publications
Treatment Guidelines and Recommendations
Toggle Treatment Guidelines and Recommendations menu options
Essential Thrombocythemia (ET)
News and Updates
Toggle News and Updates menu options
Events
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Open MPN Clinical Trials
Our Research
About Us
Toggle About Us menu options
Our Approach
Our Team
Leadership
Make a Difference
Directions
Weill Cornell Medicine
Care
Discover
Teach
Home
For Patients
For Professionals
News and Updates
Research and Clinical Trials
About Us
Home
For Professionals
Featured Publications
Refer a Patient
Featured Publications
Treatment Guidelines and Recommendations
Featured Publications
Found 2 results
Filters:
Keyword
is
United States
[Clear All Filters]
2016
Padula WV, Larson RA, Dusetzina SB, Apperley JF, Hehlmann R, Baccarani M, Eigendorff E, Guilhot J, Guilhot F, Hehlmann R et al.
. 2016.
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
.
J Natl Cancer Inst. 108(7)
Jones GH, Carrier MA, Silver RT, Kantarjian H
. 2016.
Strategies that delay or prevent the timely availability of affordable generic drugs in the United States.
.
Blood. 127(11):1398-402.
